
Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 988.7
2026-08-06 10:24:22With a decisive surge to Rs 988.7 on 6 Aug 2026, Sudeep Pharma Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.
Read full news article
Sudeep Pharma Ltd Hits All-Time High of Rs 988.7 as Momentum Builds Across Timeframes
2026-08-06 09:51:57Extending its winning streak to four sessions, Sudeep Pharma Ltd surged to a fresh all-time high of Rs 988.7 on 6 Aug 2026, outperforming both its sector and the broader market with a 1.45% gain on the day against the Sensex’s 0.31% rise.
Read full news articleAre Sudeep Pharma Ltd latest results good or bad?
2026-08-05 19:27:07Sudeep Pharma Ltd's latest financial results for Q1 FY27 present a mixed operational picture. The company reported a net profit of ₹40.55 crores, reflecting a year-on-year growth of 31.61% from ₹30.81 crores in Q1 FY26. However, this marks a sequential decline of 17.04% from the previous quarter's profit of ₹48.88 crores. The revenue for the quarter reached ₹158.27 crores, indicating a robust year-on-year growth of 26.70%, although it experienced a quarter-on-quarter decline of 13.20% from ₹182.34 crores in Q4 FY26. The operating margin for the quarter stood at 34.69%, a slight contraction from 35.13% in the same quarter last year. This margin compression, alongside a decline in the profit after tax (PAT) margin to 25.65% from 26.62% in Q4 FY26, suggests that the company is facing cost pressures that could impact its profitability moving forward. Sudeep Pharma's operational efficiency is highlighted by a ...
Read full news article
Sudeep Pharma Ltd Surges 7.7% to New 52-Week High, Outperforming Sector by 7 Percentage Points
2026-08-05 12:48:50The Sensex edged up a mere 0.01% on 5 Aug 2026, while Sudeep Pharma Ltd soared 7.69%, marking a standout session in the Pharmaceuticals & Biotechnology sector. This 7.04-percentage-point outperformance signals a distinctly stock-specific rally rather than a broad market lift.
Read full news article
Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 919.4
2026-08-05 12:11:21After a volatile session marked by a sharp intraday swing, Sudeep Pharma Ltd surged to a fresh 52-week and all-time high of Rs 919.4 on 5 Aug 2026, reflecting a powerful technical momentum that has been building steadily over recent weeks.
Read full news article
Sudeep Pharma Ltd Hits All-Time High of Rs 915 Amid Volatile Trading
2026-08-05 11:48:24After a turbulent session marked by a sharp intraday swing, Sudeep Pharma Ltd closed at a fresh all-time high of Rs 915.05 on 05 Aug 2026, extending its recent upward momentum despite opening with a 6.08% gap down.
Read full news article
Sudeep Pharma Q1 FY27: Robust Growth Masks Margin Pressures and Premium Valuation Concerns
2026-08-05 09:55:09Sudeep Pharma Ltd., the Ahmedabad-based pharmaceutical company, delivered a solid Q1 FY27 performance with consolidated net profit climbing 31.61% year-on-year to ₹40.55 crores, though sequential momentum faltered with a 17.04% quarter-on-quarter decline. The ₹10,005.55-crore market cap company saw net sales rise 26.70% YoY to ₹158.27 crores in the June 2026 quarter, maintaining its growth trajectory despite operating margin compression and rising cost pressures that warrant investor attention.
Read full news articleAre Sudeep Pharma Ltd latest results good or bad?
2026-08-04 19:22:46Sudeep Pharma Ltd's latest financial results for the quarter ended March 2026 present a mixed operational picture. The company achieved net sales of ₹182.34 crores, reflecting a sequential increase of 5.80% and a year-on-year growth of 15.73%. This indicates a strong demand for its product portfolio, marking the highest quarterly revenue in its recent history. However, despite this top-line growth, the company experienced margin compression, with the operating profit margin declining to 34.33% from 37.31% in the previous year. This contraction of 298 basis points suggests challenges in managing operational costs and competitive pricing pressures. Net profit for the quarter was reported at ₹48.88 crores, which represents a year-on-year increase of 10.61%. However, the profit margins also saw a decline, with the PAT margin decreasing to 26.62% from 28.05% in the same quarter last year. This indicates that wh...
Read full news article
Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 912.65
2026-08-03 10:13:12With a decisive surge to Rs 912.65 on 3 Aug 2026, Sudeep Pharma Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector peers.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Sudeep Pharma Ltd has declared 150% dividend, ex-date: 23 Jul 26
No Splits history available
No Bonus history available
No Rights history available






